SNSatoshi Numazawa

Satoshi Numazawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Satoshi Numazawa has a total of 112 co-authors. Here are the top co-authors by number of shared publications:

  • Takemi Yoshida

    Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan

    13 shared publications
  • Sachiko Tanaka

    Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa University School of Pharmacy

    4 shared publications
  • Takashi Ashino

    Department of Toxicology, Showa Medical University Graduate School of Pharmacy, 1-5-8 Hatanodai, Shinagawa, Tokyo, 142-8555, Japan

    4 shared publications
  • Asuka Kaizaki-Mitsumoto

    Department of Toxicology, Showa Medical University Graduate School of Pharmacy , Tokyo, 142-8555

    3 shared publications
  • Sawako Shindo

    Department of Biochemical Toxicology, Showa University School of Pharmacy, Tokyo, Japan

    3 shared publications
  • Seiji Shioda

    Department of Functional Morphology, Shonan University of Medical Science, Yokohama 244-0806, Japan

    3 shared publications

Latest Publications

  • Paternal methylphenidate exposure alters sperm miRNAs and induces intergenerational behavioral and transcriptional changes that are largely reversed by washout

    by Kanata Akaike, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa

    Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Methylphenidate (MPH), a first-line medication, is often used long-term and not routinely discontinued in individuals planning to have children. Guided by the Paternal Origins of Health and Disease framework, in this study, we investigated intergenerational effects of paternal MPH exposure and reversibility of sperm epigenetic changes. Male BALB/c mice received MPH (15 mg/kg) or vehicle for 28 days and were mated with untreated females immediately after treatment (F0-T1) or after a 40-day washout period (F0-T2). Behavioral tests and brain gene expression analyses were conducted in the offspring (F1), and sperm small noncoding RNA (sncRNA) profiles were examined in F0 males. Male offspring in the F0-T1-MPH group showed increased open-arm entry into the elevated plus maze and reduced expression of Maoa, Maob, and Bdnf in the medial prefrontal cortex. These changes were absent in the offspring derived from the F0-T2-MPH group. Sperm sncRNA sequencing identified 5,684 differentially expressed fragments in F0-T1-MPH mice, including marked alterations in miRNA-derived fragments, such as miR-34c-5p and miR-30e-5p. The target genes of these altered miRNAs were enriched in ADHD-related pathways, including axon guidance and Rap1 signaling. After washout, the number of differentially expressed sncRNA fragments decreased to 665, whereas the number of altered miRNA-derived fragments decreased from 383 to 7. These findings suggest that paternal MPH exposure may influence offspring behavior and brain gene expression through sperm miRNA alterations and that these effects are largely reversible following drug withdrawal.

  • Open Access

    Evaluation of toxicokinetic interactions mediated by plasma protein binding during amoxapine intoxication

    by Akifumi Okamoto, Yoshitaka Yamazaki, Natsumi Hattori-Usami, Kenji Momo, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa

    Toxicity enhancement mediated by plasma protein binding during intoxication remains poorly understood. It is known that in mice, brain penetration of amoxapine (AMX) increases nonlinearly with increasing doses; therefore, this study investigated its potential to enhance toxicity via plasma protein binding. AMX was added to mouse or human plasma and adjusted to therapeutic, toxic, and lethal concentrations. The plasma protein-binding ratio and free AMX concentration were measured using ultrafiltration and equilibrium dialysis. Furthermore, the binding ratios of varying concentrations of chlorpromazine, which is often co-administered with AMX in cases of overdose, was analyzed in the presence of therapeutic AMX concentrations. The binding ratio of AMX exceeded 90%, thereby demonstrating a high binding rate; however, this ratio was lower in human plasma than in mice. A nonlinear increase in free AMX concentration was observed in mouse plasma, particularly at high concentrations. In contrast, free AMX concentration showed a linear increase in human plasma. Neither the therapeutic nor toxic concentration of chlorpromazine produced any visible effects on the plasma protein binding ratio or the free AMX concentration. These results suggest that protein binding of AMX is more readily saturated in mouse plasma than in human plasma. In addition, chlorpromazine inhibits AMX binding to α1-acid glycoprotein; however, AMX may alternatively binds to albumin, which results in no apparent change in the total binding ratio. Further insights into the toxicokinetic interactions mediated by plasma protein binding are also needed for various toxic substances other than AMX.

  • Usefulness of hydrocortisone prophylaxis for oxaliplatin-induced hypersensitivity reactions: A retrospective study

    by Maho Tanaka, Masato Komuro, Yasushi Kojima, Takahiro Nishimura, Satoshi Numazawa

    Introduction: Oxaliplatin is a platinum-based drug widely used for treating colorectal cancer. However, its use is often complicated by hypersensitivity reactions and other adverse effects, including peripheral neuropathy and myelosuppression. We evaluated the efficacy of prophylactic hydrocortisone administration in preventing hypersensitivity reactions during oxaliplatin therapy in patients with colorectal cancer. Methods: Patients who received oxaliplatin between January 2017 and December 2023 were retrospectively analyzed. Among them, 53 received 100 mg of hydrocortisone as a preventive measure when the cumulative oxaliplatin dose exceeded 400 mg/m 2 or if they experienced a treatment interruption of >8 weeks. We compared the incidence and severity of hypersensitivity reactions, as well as cumulative oxaliplatin dose, between patients who received routine premedication only (the Routine group) and those who received additional hydrocortisone prophylaxis (the Prophylaxis group). Results: Overall, 370 patients were included in the study. Hypersensitivity reactions occurred in 23 patients (18 in the Routine group and 5 in the Prophylaxis group), with a significantly higher cumulative dose of oxaliplatin in the Prophylaxis group (644 vs. 1383 mg/m 2 , p = 0.0032). Severe reactions were observed only in the Routine group. Treatment discontinuation owing to hypersensitivity reactions was more common in the Routine group (five patients) than in the Prophylaxis group (one patient). Conclusions: Prophylactic administration of hydrocortisone may promote oxaliplatin treatment continuation. This approach is proposed as a potential strategy for preventing oxaliplatin-induced hypersensitivity reactions.


  • Open Access

    A Case of Metronidazole‐Induced Encephalopathy: Can Encephalopathy be Distinguished From Delirium Like Symptoms?

    by Maho Tanaka, Yasushi Kojima, Takahiro Nishimura, Satoshi Numazawa, Kenji Momo

    Although the treatment strategies differ significantly, metronidazole‐induced encephalopathy and delirium manifest with similar clinical symptoms. Therefore, the potential risk of encephalopathy should be considered when treating patients with delirium.

  • Open Access

    PEG‐23 glyceryl distearate, a multifunctional skin‐supporting material, upregulates the expression of factors associated with epidermal barrier and hydration

    by Tatsuro Miyoshi, Brian C. Keller, Sui Nakagawa, Takashi Ashino, Satoshi Numazawa

    Objective: As the outermost organ of the human body, the skin plays a critical role in protecting against external agents and oxidative stress, as well as in preventing excessive water loss. Among its layers, the stratum corneum of the epidermis is central to both barrier function and moisture retention, with its structural integrity significantly influencing skin health and appearance. Polyethylene glycol‐23 glyceryl distearate (GDS‐23) can form niosomes, liposome‐like structures with multiple layers and serve as a carrier in drug delivery systems (DDS). We previously reported that GDS‐23 exerts multiple biological effects, suppressing inflammation and enhancing the endogenous antioxidant system via Nrf2 activation through phosphorylation of the autophagy adaptor protein p62. In this study, we investigated the effects of GDS‐23 on epidermal barrier function and moisture retention using normal human epidermal keratinocytes (NHEKs) and a three‐dimensional (3D) epidermal model, mimicking human skin structure. Methods: NHEKs and the 3D epidermal model were treated with GDS‐23. Gene expression in NHEKs was analysed using real‐time polymerase chain reaction, while the levels of epidermal barrier‐ and moisture retention‐related factors in the 3D model were evaluated using immunofluorescence staining. Results: Treatment with GDS‐23 upregulated the mRNA expression of genes involved in stratum cornea formation (filaggrin and loricrin), moisture retention (aquaporin 3 and hyaluronan synthase 3) and intercellular lipid synthesis (ceramide synthase, sulfotransferase 2B1 and peroxisome proliferator‐activated receptor α) in NHEKs. Additionally, treatment with K67, which inhibits p62 phosphorylation and thereby suppresses Nrf2 activation via a non‐canonical mechanism, suppressed the GDS‐23‐induced expression of filaggrin, loricrin, ceramide synthase, sulfotransferase 2B1 and aquaporin 3. In the 3D epidermal model, GDS‐23 treatment upregulated the expression of Nrf2, downstream antioxidant factors and proteins involved in stratum corneum formation and moisture regulation. Mechanistically, GDS‐23 enhanced endogenous antioxidant function and modulated the expression of molecular markers associated with epidermal barrier and moisture retention, thereby potentially contributing to skin homeostasis. Conclusion: As GDS‐23 contributes to the maintenance of skin homeostasis, it is expected to have future applications in the cosmetic field and in the treatment of skin disorders. Overall, GDS‐23 holds promise as a “multifunctional DDS material” that promotes skin health.


  • Open Access

    Development of a risk assessment method for the detailed consideration of the effects of liquid toxic substance leakage incidents on the human body: ethanol as a model substance

    by Akio Horiguchi, Satoshi Numazawa

    To ensure safety in chemical plants handling a wide variety of liquid and gaseous hazardous substances, it is necessary to carry out highly accurate risk assessments and take appropriate measures. In this study, a risk assessment method was developed for the problem of the leakage of liquid hazardous substances. The risk assessment of toxic liquid leaks must consider the exposure of workers to the liquid and toxic gases produced by vaporization. The absorption and subsequent metabolism of hazardous substances in the body via multiple pathways after exposure to liquids and gases was calculated using a pharmacokinetic model. Estimation of exposure concentrations of toxic gases volatilized from leaked liquids was reproduced by computational fluid dynamics simulation. In this study, ethanol was selected as the hazardous substance and the risk of hazardous liquid leakage was assessed. The results of the analysis, which considered liquid and gas exposure under the conditions of the assumed scenario, showed that the maximum blood concentration of ethanol was 1640 µmol/L, which is sufficiently low compared to the concentration of 10,900 µmol/L at which acute toxic effects become apparent. These results suggest that work can be carried out safely under the conditions of the assumed scenario. The risk assessment methodology for liquid spills in this study confirms that risk assessment is possible under multiple scenarios, including individual differences, activity conditions, and the use of protective equipment.

  • Open Access

    Flunitrazepam alters the toxicokinetics of chlorpromazine enhancing its toxicity

    by Kota Nakajima, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa

    Flunitrazepam, a highly potent benzodiazepines, has a wide safety margin and widely used for insomnia treatment. However, a number of fatal poisoning cases involving a combination of flunitrazepam and other drugs have been reported. In instances of drug overdose deaths involving flunitrazepam in Japan, antipsychotic drugs like chlorpromazine are frequently used concomitantly. This study seeks to elucidate the pharmacokinetic interactions during the overdose of concurrent drugs, with a specific focus on the toxic effects of elevated doses of flunitrazepam and chlorpromazine in mice. Male ICR mice were intraperitoneally administered chlorpromazine (90 mg/kg) and flunitrazepam (200 mg/kg) either alone or concurrently. Body temperature was measured up to 24 hr after administration, and the number of deaths within 24 hr was quantified for each group. Additionally, flunitrazepam, chlorpromazine, and its active metabolite 7-hydroxychlorpromazine concentrations in serum and brain extracellular fluid were measured up to 24 hr after administration. Flunitrazepam enhanced the hypothermic effect of chlorpromazine, and acute intoxication deaths occurred only in the combination group. Cmax and AUC0-24h of flunitrazepam in serum and brain were not affected by concomitant administration with chlorpromazine. While flunitrazepam significantly increased the AUC0-24h of chlorpromazine, and the Cmax and AUC0-24h of 7- hydroxychlorpromazine in serum. Flunitrazepam was shown to alter the toxicokinetics of chlorpromazine when administered in combination, thereby augmenting the toxicity of chlorpromazine and leading to lethal drug intoxication. This study underscores the significance of comprehending toxicokinetics not only for individual agents but also when utilized in combination.

  • Open Access

    Simulation-based risk assessment for the leakage of toxic substances in a chemical plant and the effects on the human body: ethanol as a working model

    by Akio Horiguchi, Satoshi Numazawa

    Chemical plants must handle a wide variety of hazardous substances. To ensure safety in such plants, it is necessary to conduct extensive and highly accurate risk assessments. In this study, we aimed at developing a method that enables flexible and accurate risk assessment. We combined two different simulation tools to reproduce the phenomena of toxic gas leakage and diffusion as well as its impact on human health. The atmospheric diffusion after the leakage of toxic gas was simulated by computational fluid dynamics (CFD). Assuming the movement line of the person, toxic gas absorption and subsequent metabolism were calculated by a physiologically based pharmacokinetic (PBPK) model. From this, changes in blood concentration of toxic substances with time were simulated and we evaluated the effects of toxic gases on human body. Ethanol was selected as a toxic gas in this study. Based on the assumed scenario, the diffusion of leaked ethanol gas was calculated by CFD leading to the confirmation that the concentration of ethanol gas varies significantly with wind speed, human position, and elapsed time. The PBPK model showed that the maximum blood concentration of ethanol was 161 µmol/L, which is sufficiently low compared to that of ethanol poisoning (i.e., 10,900 µmol/L). These results suggest that the effects on the human body are relatively low and the evacuation can be performed safely. Compared to conventional methods of risk assessment, our new method allows the risk assessment of multiple scenarios, namely interindividual differences, activity status and the used of protective equipment.